A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

NCT06178991 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8795

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
COVID-19

Interventions

BIOLOGICAL: Influenza and COVID-19 Combination A
BIOLOGICAL: Licensed influenza vaccine
BIOLOGICAL: COVID-19 Vaccine
BIOLOGICAL: Influenza and COVID-19 Combination B
BIOLOGICAL: Placebo
BIOLOGICAL: Investigational influenza vaccine

Sponsor

BioNTech SE

Collaborators

[object Object]